Intestinal immunoglobulin (Ig)A binds to distinct commensals and pathobionts, but do these IgA-coated bacterial communities define clinical characteristics of inflammatory disease? In this issue of Cell Host & Microbe, Shapiro et al. comprehensively analyze IgA-coated bacteria in new onset inflammatory bowel disease (IBD), revealing their potential in guiding precision therapy and diagnostic stratification.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chom.2020.12.014 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!